PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF PSI-352938, A NOVEL NUCLEOTIDE POLYMERASE INHIBITOR FOR HCV, FOLLOWING SINGLE ASCENDING ORAL DOSES IN HEALTHY SUBJECTS

被引：0
|
作者：
Symonds, William [1 ]
Denning, Jill M. [1 ]
Albanis, Efsevia [1 ]
Wright, Robert [2 ]
Lai, Alexander [2 ]
Berrey, Michelle [1 ]
机构：
[1] Pharmasset Inc, Princeton, NJ USA
[2] Covance Clin Res Unit Inc, Madison, WI USA
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1890
引用
收藏
页码：1219A / 1219A
页数：1
相关论文
共 50 条
  • [1] ANTIVIRAL ACTIVITY, PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF PSI-7851, A NOVEL NUCLEOTIDE POLYMERASE INHIBITOR FOR HCV, FOLLOWING SINGLE AND 3 DAY MULTIPLE ASCENDING ORAL DOSES IN HEALTHY VOLUNTEERS AND PATIENTS WITH CHRONIC HCV INFECTION
    Rodriguez-Torres, Maribel
    Lawitz, Eric
    Flach, Stephen
    Denning, Jill M.
    Albanis, Efsevia
    Symonds, William
    Berrey, M. M.
    HEPATOLOGY, 2009, 50 (06) : 11A - 11A
  • [2] A STUDY OF THE SAFETY AND PHARMACOKINETICS OF SINGLE ASCENDING ORAL DOSES OF INX-08189, A NUCLEOTIDE POLYMERASE INHIBITOR, IN HEALTHY SUBJECTS
    Patti, J.
    Matson, M.
    Boehlecke, B.
    Barry, A.
    Wenzel, E.
    Pentikis, H.
    Alam, J.
    Henson, G.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S187 - S187
  • [3] Pharmacokinetics, Safety, and Tolerability of GS-9851, a Nucleotide Analog Polymerase Inhibitor for Hepatitis C Virus, following Single Ascending Doses in Healthy Subjects
    Denning, Jill
    Cornpropst, Melanie
    Flach, Stephen D.
    Berrey, Michelle M.
    Symonds, William T.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (03) : 1201 - 1208
  • [4] SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF ASCENDING SINGLE ORAL DOSES OF CC-930, A NOVEL JNK INHIBITOR, IN HEALTHY SUBJECTS
    Ye, Y.
    Kong, L.
    Assaf, M.
    Liu, L.
    Wu, A.
    Choudhury, S.
    Laskin, O.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S31 - S31
  • [5] Safety, Tolerability and Pharmacokinetics of Single Ascending and Multiple Oral Doses of Tegoprazan in Healthy Chinese Subjects
    Jinjie He
    Guoying Cao
    Jicheng Yu
    Jingjing Wang
    Nengneng Cheng
    Jufang Wu
    Jing Zhang
    Xiaojie Wu
    Basheng Zhang
    Jiayan Lu
    Shangzhi Chen
    Clinical Drug Investigation, 2021, 41 : 89 - 97
  • [6] Safety, Tolerability and Pharmacokinetics of Single Ascending and Multiple Oral Doses of Tegoprazan in Healthy Chinese Subjects
    He, Jinjie
    Cao, Guoying
    Yu, Jicheng
    Wang, Jingjing
    Cheng, Nengneng
    Wu, Jufang
    Zhang, Jing
    Wu, Xiaojie
    Zhang, Basheng
    Lu, Jiayan
    Chen, Shangzhi
    CLINICAL DRUG INVESTIGATION, 2021, 41 (01) : 89 - 97
  • [7] Pharmacokinetics, Safety, and Tolerability of Rolapitant Administered Intravenously Following Single Ascending and Multiple Ascending Doses in Healthy Subjects
    Wang, Xiaodong
    Zhang, Zhi-Yi
    Wang, Jing
    Powers, Dan
    Arora, Sujata
    Lu, Sharon
    Kansra, Vikram
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (02): : 160 - 171
  • [8] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE HCV POLYMERASE INHIBITOR ABT-333 FOLLOWING MULTIPLE ASCENDING DOSES AND EFFECT OF CO-ADMINISTRATION OF KETOCONAZOLE IN HEALTHY SUBJECTS
    Menon, R.
    Cohen, D.
    Nada, A.
    Chiu, Y. -L.
    Podsadecki, T.
    Awni, W.
    Bernstein, B.
    Klein, C.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S348 - S348
  • [9] Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses
    Moore, KHP
    Hussey, EK
    Shaw, S
    Fuseau, E
    Duquesnoy, C
    Pakes, GE
    CEPHALALGIA, 1997, 17 (04) : 541 - 550
  • [10] Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects
    Sheng, Lei
    Cao, Wei
    Lin, Pingping
    Chen, Weili
    Xu, Hongrong
    Zhong, Chunjiu
    Yuan, Fei
    Chen, Hanjing
    Li, Hui
    Liu, Chao
    Yang, Mengjie
    Li, Xuening
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 1101 - 1110
12345